Integration of peritoneal dialysis and transplantation programs

Peritoneal Dialysis International

Volumn 17, Issue SUPPL. 2, 1997, Pages

  Maiorca, Rosario ^a   Sandrini, Silvio ^a   Cancarini, Giovanni C ^a   Gaggia, Paola ^a   Chiappini, Raffaella ^a   Setti, Gisella ^a   Pola, Alessandra ^a   Maffeis, Roberto ^a   Cardillo, Massimo ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Cost; Hemodialysis; Kidney transplantation; Survival

Indexed keywords

ALBUMIN;

ADULT; BLADDER CAPACITY; BLOOD GROUP; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CYTOMEGALOVIRUS INFECTION; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEPATITIS B; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL; TREATMENT OUTCOME;

EID: 0030779511     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089701702s34     Document Type: Conference Paper

References (16)

1. Maiorca R, Sandrini S, Cancarini GC, et al. Kidney Transplantation in Peritoneal Dialysis Patients. Perit Dial Int 1994; 14 (Suppl 3): S162-8.
2. Canaud B, Mion C. Role of continuous ambulatory peritoneal dialysis (CAPD) in a program for the treatment of chronic renal insufficiency. Problems posed by transfer of CAPD to transplantation or hemodialysis. Néphrologie 1995, 16:129-35.
3. Bitker MO. Peritoneal dialysis and renal or renal-pancreas transplantation.Néphrologie 1995, 16:137-40.
4. Horn S, Holzer H, Horina JH. Spontaneous bacterial peritonitis in a patient with nephrogenic ascites during an episode of acute renal transplant rejection.Am J Kidney Dis 1996; 27 (3):441-3
5. Maiorca R, Cristinelli L, Scolari F, et al. Cyclosporine toxicity can be minimized by careful monitoring of blood levels. Transplant Proc 1985; 17 (Suppl 2):54-9.
6. Pearson JC, Amend WJ Jr, Vincenti FG, et al. Posttransplantation pyelonephritis: factors producing low patient and transplant morbidity. J Urol 1980; 123:153-6.
7. Cancarini GC, Brunori G, Camerini C, Brasa S, Manili L, Maiorca R. Renal function recovery and maintenance of residual diuresis in PD and hemodialysis. Perit Dial Bull 1986; 6:77-9.
8. Lysaght M, Vonesh E, Ibels L, et al. Decline of residual renal function in hemodialysis and CAPD patients: a risk adjusted growth function analysis (Abstract). ASAIO Trans 1988; 34:84.
9. Rottembourg J. Residual renal function and recovery of renal function in patients treated by CAPD.Kidney Int 1993; 43 (Suppl 40):S106-10.
10. Maiorca R, Brunori G, Zubani R, et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 1995; 10:2295-305.
11. Debure A, Degos F, Pol S, et al. Liver disease and hepatic complications in renal transplant patients. Adv Nephrol 1988; 17:375-400.
12. Mioli VA, Balestra E., Bibiano L, et al. Epidemiology of viral hepatitis in dialysis centers: a national survey. Nephron 1992; 61:278-83.
13. Maiorca R, Vonesh EF, Cavalli PL, et al. A multicenter selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int 1991; 11:118-27.
14. Maiorca R, Cancarini GC, Zubani R, et al. CAPD long-term viability: a comparison with HD. Perit Dial Int 1996; 16:276-87.
15. Gokal R. Quality of life. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. Dordrecht, the Netherlands: Kluwer Academic Publishers, 1994; 679-98.
16. Nissenson AR, Prichard SS, Cheng IK, et al. Non-medical factors that impact on ESRD modality selection. Kidney Int 1993; (Suppl 40):S120-7.